NCT04183257View on ClinicalTrials.gov

Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

July 30, 2017

Conditions
Vitamin D DeficiencyInsulin ResistanceDiabetes Mellitus, Type 2
Interventions
DRUG

oral vitamin D

oral Vitamin D 400IU will be given and will be escalated every 2 weeks.

All Listed Sponsors
lead

King Edward Medical University

OTHER

NCT04183257 - Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics | Biotech Hunter | Biotech Hunter